← Browse by Condition
Medical Condition

acute coronary syndrome

Total Trials
16
Recruiting Now
16
Trial Phases
Phase 2, Phase 3
NCT05926271 Phase 2
Recruiting

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy

Enrollment
200 pts
Location
Netherlands
Sponsor
St. Antonius Hospital
View Trial →
NCT05646849
Recruiting

Using a Connected Application to Maintain Physical Activity After Cardiac Rehabilitation

Enrollment
208 pts
Location
France
Sponsor
University Hospital, Angers
View Trial →
NCT06215989
Recruiting

Treatment of ACuTe Coronary Syndromes With Low-dose colchICine

Enrollment
6,574 pts
Location
China
Sponsor
Beijing Anzhen Hospital
View Trial →
NCT06464042
Recruiting

Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease

Enrollment
4,272 pts
Location
Spain
Sponsor
pablo Juan-Salvadores
View Trial →
NCT05305482
Recruiting

DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial

Enrollment
3,520 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →
NCT04344912
Recruiting

Impact of COVID19 Outbreak in Cardiac Acute Care

Enrollment
500 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT06955143
Recruiting

A Study on the Peripheral Blood in Patients With Acute Coronary Syndrome

Enrollment
310 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
View Trial →
NCT04998227
Recruiting

Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction

Enrollment
300 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
View Trial →
NCT05457582
Recruiting

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

Enrollment
1,212 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
View Trial →
NCT06332859
Recruiting

Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease

Enrollment
130 pts
Location
Austria
Sponsor
Pensionsversicherungsanstalt
View Trial →
NCT05918861 Phase 3
Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Enrollment
2,000 pts
Location
United States, Canad...
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT05412927
Recruiting

AngelMed Guardian® System PMA Post Approval Study

Enrollment
500 pts
Location
United States
Sponsor
Angel Medical Systems
View Trial →
NCT05325034
Recruiting

Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

Enrollment
2,000 pts
Location
Australia, China, In...
Sponsor
Stephen Nicholls
View Trial →
NCT06255678
Recruiting

Angio-based Final Functional Effect of PCI

Enrollment
2,005 pts
Location
Poland
Sponsor
Medical University of Warsaw
View Trial →
NCT06384846
Recruiting

AI Algorithms in Prediction of ACS Based on Leukocyte Properties

Enrollment
2,700 pts
Location
Austria
Sponsor
RobotDreams GmbH
View Trial →
NCT05051917
Recruiting

The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome

Enrollment
500 pts
Location
Italy
Sponsor
Federico II University
View Trial →